Quarterly report pursuant to Section 13 or 15(d)

Stock Incentive Plan (Tables)

v3.21.2
Stock Incentive Plan (Tables)
9 Months Ended
Sep. 30, 2021
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of Stock-Based Compensation Expense Recognized The following table reflects the components of stock-based compensation expense recognized in the Condensed Consolidated Statements of Operations for the three- and
six-
month periods ended September 30, 2021 and 2020:
 
    
Three Months Ended

September 30,
    
Nine Months Ended

September 30,
 
               
    
2020
    
2021
    
2020
    
2021
 
                             
    
(Dollars in thousands)
    
(Dollars in thousands)
 
Stock option compensation expense included in unallocated corporate
expenses
   $ 30     
$
23
 
   $ 122     
$
75
 
Stock option compensation expense included in broadcast operating
expenses
     32     
 
31
 
     106     
 
92
 
Stock option compensation expense included in digital media operating
expenses
     12     
 
24
 
     44     
 
73
 
Stock option compensation expense included in publishing operating
expenses
     —       
 
—  
 
     1     
 
—  
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Total stock-based compensation expense,
pre-tax
   $ 74     
$
78
 
   $ 273     
$
240
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Tax expense for stock-based compensation expense
     (19   
 
(20
     (71   
 
(62
    
 
 
    
 
 
    
 
 
    
 
 
 
Total stock-based compensation expense, net of tax
   $ 55     
$
58
 
   $ 202     
$
178
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Schedule of Weighted-Average Assumptions Used to Estimate Fair Value of Stock Options and Restricted Stock Awards using Black-Scholes Option Valuation Model
The weighted-average assumptions used to estimate the fair value of the stock options using the Black-Scholes valuation model were as follows for the three- and nine-month periods ended September 30, 2021 and 2020:
 
    
Three Months Ended
    
Nine Months Ended
   
Three Months Ended
   
Nine Months Ended
 
    
September 30, 2020
    
September 30, 2020
   
September 30, 2021
   
September 30, 2021
 
Expected volatility
     n/a        53.96     79.99     75.98
Expected dividends
     n/a        7.30     0.00     0.00
Expected term (in years)
     n/a        7.6       8.0       7.8  
Risk-free interest rate
     n/a        1.14     1.27       1.03
Schedule of Stock Option Activity
Activity with respect to the company’s option awards during the nine-month period ended September 30, 2021 is as follows:
 
Options
   Shares     Weighted
Average
Exercise Price
     Weighted Average
Grant Date
Fair Value
     Weighted Average
Remaining
Contractual Term
     Aggregate
Intrinsic
Value
 
                                   
    
(Dollars in thousands, except weighted average exercise price and weighted average grant date fair value)
 
Outstanding at January 1, 2021
     2,291,020     $  3.23      $  1.52        4.3 years      $ —    
Granted
     270,000       2.14        1.55                 —    
Exercised
     (192,507     2.11        0.97                 200  
Forfeited or expired
     (157,446     6.73        4.74                 —    
    
 
 
                                    
Outstanding at September 30, 2021
  
 
2,211,067
 
 
$
2.95
 
  
$
1.34
 
  
 
4.4 years
 
  
$
 2,484
 
    
 
 
                                    
Exercisable at September 30, 2021
  
 
1,209,942
 
 
$
3.84
 
  
$
1.75
 
  
 
2.6 years
 
  
$
640
 
    
 
 
                                    
Expected to Vest
  
 
950,568
 
 
$
2.97
 
  
$
1.35
 
  
 
4.3 years
 
  
$
2,391
 
    
 
 
                                    
Schedule of Information Regarding Restricted Stock Activity
Activity with respect to the company’s restricted stock awards during the nine-month period ended September 30, 2021 is as follows:
 
Restricted Stock Awards
   Shares      Weighted Average
Grant Date
Fair Value
     Weighted Average
Remaining Contractual Term
     Aggregate
Intrinsic Value
 
                             
    
(Dollars in thousands, except weighted average exercise price and weighted average
grant date fair value)
 
Outstanding at January 1, 2021
     107,990      $ 1.85        1.67 years      $  112  
Granted
     —          —          —          —    
Lapsed
     (41,323      2.42        —          100  
Forfeited
     —          —          —          —    
    
 
 
                            
Outstanding at September 30, 2021
  
 
66,667
 
  
$
1.50
 
  
 
0.02 years
 
  
$
247